Between July and September 2026, the IPO market saw remarkable activity, with seven newly listed stocks seeing their prices double from initial offerings. Despite the triumphs, others faced steep declines. Overall, these IPOs yielded an average return of 36.46%, standing in stark contrast to the wider market's lackluster performance. Investors should be diligent in evaluating company fundamentals before pursuing new investments.
In recent weeks, the NSE 500 index has faced significant setbacks, with declines in numerous stocks due to mounting economic pressures and foreign selling activities. Stock losses have ranged between 18% to 64% over the past two months. Contributing factors, such as surging crude oil prices and higher US bond yields, have turned market sentiment sour.
Vishal Nirmiti IPO entered Day 2 of bidding with the Rs 178-crore issue subscribed 5% on Day 1, led by 6% subscription in the retail category. The IPO comprises a Rs 145-crore fresh issue and Rs 33-crore OFS, with the issue closing on October 5. premium listing. Shares are expected to list on NSE and BSE on October 8.
Cupid shares hit a 52-week high after raising its FY27 guidance for the second time in two weeks, targeting Rs 800 crore revenue and Rs 250 crore net profit. Driven by strong domestic and international demand, the multibagger stock has surged 617% over the past year.
The Sensex, which closed at 72,480.29 on September 30, opened at 72,192.89 on Thursday; Nifty 50, which closed at 22,620.45, opened at 22,543.70
Goldman Sachs has revised its forecast for the next US interest rate hike from October to December. This change comes after lower-than-expected inflation data was released for August. The personal consumption expenditures price index increased 3.4% annually, falling short of economists' predictions. Market participants are now closely watching the upcoming US nonfarm payrolls report scheduled for release on Friday.
Business Excellence Trust III, a fund of Motilal Oswal Alternates, offloaded 23.28 lakh shares of Goa-based Molbio Diagnostics at an average price of ₹1,315.01 apiece
South Korean shares slipped despite record September exports, as elevated oil prices and uncertainty over Middle East energy supplies weighed on sentiment. The KOSPI fell 0.21%, while the won weakened and bond yields rose. Exports surged 83.5%, driven by semiconductor shipments and strong AI-related demand, but foreign investors remained net sellers.
Jefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correction driven by regulatory concerns over drug and consumable price caps. The brokerage expects strong fundamentals and strategic price adjustments to help limit long-term EBITDA impact.
